Zalupski M - Search Results

1

Phase II trial of recombinant human macrophage colony-stimulating factor in metastatic soft tissue sarcoma.

Momin FA, Zalupski M, Heilbrun LK, Flaherty L, Fyfe G, Baker LH, Redman BG. Momin FA, et al. Among authors: zalupski m. J Immunother Emphasis Tumor Immunol. 1994 Oct;16(3):224-8. doi: 10.1097/00002371-199410000-00007. J Immunother Emphasis Tumor Immunol. 1994. PMID: 7834122 Clinical Trial.

2

Genomics driven precision oncology in advanced biliary tract cancer improves survival.

Kumar-Sinha C, Vats P, Tran N, Robinson DR, Gunchick V, Wu YM, Cao X, Ning Y, Wang R, Rabban E, Bell J, Shankar S, Mannan R, Zhang Y, Zalupski MM, Chinnaiyan AM, Sahai V. Kumar-Sinha C, et al. Among authors: zalupski mm. Neoplasia. 2023 Aug;42:100910. doi: 10.1016/j.neo.2023.100910. Epub 2023 May 31. Neoplasia. 2023. PMID: 37267699 Free PMC article.

3

Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study.

Zalupski M, Metch B, Balcerzak S, Fletcher WS, Chapman R, Bonnet JD, Weiss GR, Ryan J, Benjamin RS, Baker LH. Zalupski M, et al. J Natl Cancer Inst. 1991 Jul 3;83(13):926-32. doi: 10.1093/jnci/83.13.926. J Natl Cancer Inst. 1991. PMID: 2067035 Clinical Trial.

4

Cellular yields and DNA content parameters in osteogenic sarcomas.

Zalupski M, Ryan JR, Ensley J, Baker L. Zalupski M, et al. Chir Organi Mov. 1990;75(1 Suppl):15-7. Chir Organi Mov. 1990. PMID: 2249516 No abstract available.

5

A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcoma.

Zalupski MM, Ensley JF, Ryan J, Selvaggi S, Baker LH, Wolman SR. Zalupski MM, et al. Cancer. 1990 Sep 15;66(6):1176-82. doi: 10.1002/1097-0142(19900915)66:6<1176::aid-cncr2820660617>3.0.co;2-k. Cancer. 1990. PMID: 2400969

6

Ifosfamide.

Zalupski M, Baker LH. Zalupski M, et al. J Natl Cancer Inst. 1988 Jun 15;80(8):556-66. doi: 10.1093/jnci/80.8.556. J Natl Cancer Inst. 1988. PMID: 3286879 Review.

7

Systemic adjuvant chemotherapy for soft tissue sarcomas.

Zalupski MM, Baker LH. Zalupski MM, et al. Hematol Oncol Clin North Am. 1995 Aug;9(4):787-800. Hematol Oncol Clin North Am. 1995. PMID: 7490241 Review.

8

Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomas.

Blair SC, Zalupski MM, Baker LH. Blair SC, et al. Among authors: zalupski mm. Am J Clin Oncol. 1994 Dec;17(6):480-4. doi: 10.1097/00000421-199412000-00005. Am J Clin Oncol. 1994. PMID: 7977164 Clinical Trial.

9

Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group study.

Zalupski MM, Benedetti J, Balcerzak SP, Hutchins LF, Belt RJ, Hantel A, Goodwin JW. Zalupski MM, et al. Invest New Drugs. 1993 Nov;11(4):337-41. doi: 10.1007/BF00874435. Invest New Drugs. 1993. PMID: 8157477 Clinical Trial.

10

Development and optimization of tissue preparative methodology for DNA content analysis of soft tissue neoplasms.

Zalupski MM, Ryan JR, Ensley JF, Maciorowski Z, Pietraszkiewicz H, Hussein ME, Kukuruga M, Sundareson AS, Baker LH. Zalupski MM, et al. Cytometry. 1993 Nov;14(8):922-30. doi: 10.1002/cyto.990140811. Cytometry. 1993. PMID: 8287735 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters